Literature DB >> 1636882

Ookinete rates in Afrotropical anopheline mosquitoes as a measure of human malaria infectiousness.

J C Beier1, R S Copeland, R Mtalib, J A Vaughan.   

Abstract

Anopheles gambiae s.1. and An. funestus were sampled for Plasmodium spp. ookinetes in two P. falciparum-endemic sites in western Kenya. Since the ookinete is a transitional stage of short duration, occurring after fertilization and before oocyst development, only females in the half-gravid and gravid stages of blood digestion were examined. Preparations of homogenized midguts were spotted onto microslides and examined microscopically after staining with Giemsa. Overall, ookinetes were detected in 4.4% of 1,079 anophelines examined over an eight-month period. Anopheles funestus had higher ookinete rates than An. gambiae s.1., and ookinete rates were higher in half-gravid than in gravid An. gambiae s.1. Geometric mean numbers of ookinetes per infected female were less than five for each species at the two sites, and the maximum number observed was only 12. The low frequencies and numbers of ookinetes were sufficient to produce sporozoite rates of 4-18% in the vector populations. The intense transmission of P. falciparum in these two sites is maintained by anthropophilic vectors where only one in 23 blood meals initiates an infection of generally less than five ookinetes. Relationships between human malaria infectiousness and vector infectivity are dependent upon the high efficiency of the developmental transition from the ookinete to the subsequent oocyst and sporozoite stages.

Entities:  

Mesh:

Year:  1992        PMID: 1636882     DOI: 10.4269/ajtmh.1992.47.41

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.

Authors:  Sophie H Adjalley; Geoffrey L Johnston; Tao Li; Richard T Eastman; Eric H Ekland; Abraham G Eappen; Adam Richman; B Kim Lee Sim; Marcus C S Lee; Stephen L Hoffman; David A Fidock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

2.  Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

Authors:  Kawsar R Talaat; Ruth D Ellis; Janet Hurd; Autumn Hentrich; Erin Gabriel; Noreen A Hynes; Kelly M Rausch; Daming Zhu; Olga Muratova; Raul Herrera; Charles Anderson; David Jones; Joan Aebig; Sarah Brockley; Nicholas J MacDonald; Xiaowei Wang; Michael P Fay; Sara A Healy; Anna P Durbin; David L Narum; Yimin Wu; Patrick E Duffy
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

3.  Optimal Population-Level Infection Detection Strategies for Malaria Control and Elimination in a Spatial Model of Malaria Transmission.

Authors:  Jaline Gerardin; Caitlin A Bever; Busiku Hamainza; John M Miller; Philip A Eckhoff; Edward A Wenger
Journal:  PLoS Comput Biol       Date:  2016-01-14       Impact factor: 4.475

4.  Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.

Authors:  Hans de Graaf; Ruth O Payne; Iona Taylor; Kazutoyo Miura; Carol A Long; Sean C Elias; Marija Zaric; Angela M Minassian; Sarah E Silk; Lee Li; Ian D Poulton; Megan Baker; Simon J Draper; Diane Gbesemete; Nathan J Brendish; Filipa Martins; Arianna Marini; David Mekhaiel; Nick J Edwards; Rachel Roberts; Johan Vekemans; Sarah Moyle; Saul N Faust; Eleanor Berrie; Alison M Lawrie; Fergal Hill; Adrian V S Hill; Sumi Biswas
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.